Meridian Clinical Trials Paul-TanPiengco

Chairman & CEO of VITRUVIAN BioMedical, Inc. which is developing an Alzheimer Disease Blood Test and Therapeutic Vaccine targeting both ABeta and TAU. First company founded was Wadley Biosciences/LPL which was a joint venture between Wadley Institutes and Phillips Petroleum with focus on cancer and infectious disease, 1987-1992. The second company founded was Cytoclonal Pharmaceutics, which went public with an IPO in 1995, and entered into a licensing agreement with Bristol Myers on Taxol production, and was merged to create OPKO Health. Former Chairman & CEO of HemoBioTech, Inc., developing HemoTech as viable substitute for human red blood cells.

Speaker Details
Events of the Speaker
You might also love these events.
November 22, 2021
Lorem ipsum dolor sit amet, voluptua iracundia an pri, his utinam principes dignissim ad. Ne nec dolore oblique nusquam, cu luptatum volutpat delicatissimi has.
Upcoming